Keratoconus (KC) is an eye disease characterized by the progressive thinning and protrusion of the cornea, which results in the loss of visual acuity. This disorder remains poorly understood, although recent studies indicate the involvement of genetic and environmental factors. Recently, we have found that the distribution of the cross-linking enzyme lysyl oxidase (LOX) is markedly decreased in about 63 % of keratoconic specimens. Similarly, LOX activity is significantly reduced by 38 % compared to control tissue. Nearly 70 systemic disorders have been reported in association with KC, most of them affecting the extracellular matrix. In this review we attempted to ascertain whether any KC-associated diseases exhibit signs that may reflect LOX impairment. We hypothesized that very similar changes in the extracellular matrix, particularly at the level of collagen metabolism, including LOX impairment in mitral leaflets, may reflect an association between KC and mitral valve prolapse. Moreover, this putative association is supported by the high frequency of Down syndrome in both diseases. Among other disorders that have been found to coincide with KC, we did not find any in which the LOX enzyme may be directly or indirectly impaired. On the other hand, in cases where KC is present along with other connective tissue disorders (Marfan syndrome, Ehlers-Danlos syndrome and others), KC may not arise as a localized manifestation, but rather may be induced as the result of a more complex connective tissue disorder.

Laboratory of Biology and Pathology of Eye 1st Faculty of Medicine Institute of Inherited Metabolic Disorders Charles University and General University Hospital Prague Czech Republic

Zobrazit více v PubMed

Am J Ophthalmol. 2000 May;129(5):667-8 PubMed

Exp Eye Res. 1983 Feb;36(2):305-15 PubMed

Oral Surg Oral Med Oral Pathol. 1988 Oct;66(4):445-7 PubMed

Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2466-76 PubMed

Annu Rev Med. 2012;63:277-92 PubMed

Invest Ophthalmol Vis Sci. 1981 Jun;20(6):738-50 PubMed

Clin Genet. 1973;4(1):8-16 PubMed

Br J Ophthalmol. 1963 Jun;47:321-30 PubMed

J Heart Valve Dis. 1998 Jul;7(4):460-6 PubMed

Cell Struct Funct. 2012;37(1):75-80 PubMed

Arch Ophthalmol. 1989 Oct;107(10):1507-10 PubMed

Prog Nucleic Acid Res Mol Biol. 2001;70:1-32 PubMed

Clin Ophthalmol. 2012;6:97-101 PubMed

Biochim Biophys Acta. 2009 Jul;1790(7):637-49 PubMed

Am J Dis Child. 1970 Feb;119(2):171-5 PubMed

Cornea. 2012 Jun;31(6):716-9 PubMed

J R Soc Med. 1992 Aug;85(8):446-8 PubMed

Middle East Afr J Ophthalmol. 2011 Jan;18(1):2-6 PubMed

Ophthalmology. 1982 Jan;89(1):35-7 PubMed

Invest Ophthalmol Vis Sci. 2012 Jun 28;53(7):4152-7 PubMed

Cornea. 1993 Jan;12(1):54-9 PubMed

Surv Ophthalmol. 2012 May-Jun;57(3):264-71 PubMed

Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1117-24 PubMed

Acta Ophthalmol. 2012 Jun;90(4):375-9 PubMed

Ophthalmic Physiol Opt. 1990 Oct;10(4):360-2 PubMed

Med J Aust. 1975 May 3;1(18):571-3 PubMed

Arq Bras Cardiol. 2009 Sep;93(3):307-11 PubMed

J Biol Chem. 1992 Apr 25;267(12):8666-71 PubMed

Circulation. 1981 Jul;64(1):121-5 PubMed

Mol Vis. 2011;17:2482-94 PubMed

Am J Med. 1979 Nov;67(5):863-6 PubMed

S Afr Med J. 1977 Aug 27;52(10):403-5 PubMed

J Cell Biol. 1986 Sep;103(3):1121-8 PubMed

Invest Ophthalmol Vis Sci. 2005 Mar;46(3):823-32 PubMed

Am J Med Genet. 1990 Oct;37(2):213-23 PubMed

Invest Ophthalmol Vis Sci. 2011 Aug 03;52(9):6181-91 PubMed

Arch Pathol. 1974 Aug;98(2):134-8 PubMed

J Neural Transm (Vienna). 2011 Jul;118(7):1091-9 PubMed

Ophthalmic Physiol Opt. 2002 Nov;22(6):511-5 PubMed

Cornea. 2011 Feb;30(2):154-7 PubMed

Graefes Arch Clin Exp Ophthalmol. 1991;229(2):164-71 PubMed

Clin Exp Ophthalmol. 2001 Dec;29(6):345-51 PubMed

Invest Ophthalmol Vis Sci. 2011 Jul 15;52(8):5240-50 PubMed

N Engl J Med. 1982 Jul 22;307(4):228-31 PubMed

Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4746-52 PubMed

Curr Opin Cardiol. 2007 May;22(3):171-5 PubMed

Am J Hum Genet. 1999 Nov;65(5):1238-41 PubMed

Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1256-63 PubMed

West J Nurs Res. 2005 Jun;27(4):390-405; discussion 406-10 PubMed

Acta Ophthalmol Suppl. 1986;178:1-64 PubMed

Exp Eye Res. 1999 Nov;69(5):475-81 PubMed

Biochem J. 1978 Sep 1;173(3):885-94 PubMed

Ann Thorac Surg. 2004 Feb;77(2):532-6 PubMed

Am J Ophthalmol. 1986 Mar 15;101(3):267-73 PubMed

J Neural Transm (Vienna). 2011 Jul;118(7):1111-4 PubMed

Arch Ophtalmol Rev Gen Ophtalmol. 1972 Aug-Sep;32(8):563-70 PubMed

Exp Eye Res. 2012 Nov;104:74-81 PubMed

Ophthalmic Genet. 2010 Dec;31(4):252-6 PubMed

Biosci Biotechnol Biochem. 2008 Nov;72(11):3067-70 PubMed

Surv Ophthalmol. 1998 Jan-Feb;42(4):297-319 PubMed

Curr Opin Ophthalmol. 2006 Aug;17(4):356-60 PubMed

Circulation. 1976 Jul;54(1):3-14 PubMed

Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1081-6 PubMed

J Struct Biol. 2010 Mar;169(3):424-30 PubMed

Acta Ophthalmol. 2012 Jun;90(4):e303-9 PubMed

J Ment Defic Res. 1991 Jun;35 ( Pt 3):194-203 PubMed

Biochim Biophys Acta. 2003 Apr 11;1647(1-2):220-4 PubMed

Biochem J. 1985 Sep 15;230(3):639-43 PubMed

Tex Heart Inst J. 1994;21(4):267-71 PubMed

Ophthalmology. 1991 Feb;98(2):170-6 PubMed

Am J Physiol Cell Physiol. 2007 Jun;292(6):C2095-102 PubMed

J Biol Chem. 2001 Jun 22;276(25):22537-43 PubMed

Zhonghua Yan Ke Za Zhi. 2011 Mar;47(3):235-41 PubMed

J Clin Invest. 1994 Apr;93(4):1716-21 PubMed